Journal of Diabetes Research (Jan 2024)
Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM
Abstract
Conclusion: MLT levels decreased in patients with T2DM and were associated with neuropsychiatric impairments and inflammatory status, and MLT might be developed as a therapeutic agent and predictive indicator for T2DM-associated executive impairment and depression status.